(Date:12/2/2009)... Israel, December 2 Gamida Cell announced today,a ... and,efficacy of a gene therapy product which combines ... The product may have potential to,treat inherited anemias ... Gamida Cell is developing a series of ...
(Date:12/2/2009)... -- Simcere Pharmaceutical Group,("Simcere" or the "Company") (NYSE: ... in the development, manufacturing, and marketing of branded,generic ... 105 of,its drugs have been included in China,s ... China,s Ministry of Human Resources and Social,Security on ...
(Date:12/2/2009)... life sciences, ranked Photometrics’ Evolve “Intelligent” EMCCD camera fourth among ... ... (PRWEB) December 2, 2009 -- The ... designer and manufacturer of high-performance CCD and EMCCD cameras for ...
(Date:12/1/2009)... PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ) today announced ... of approximately $57 million, as compared with $69 million for ... results was the first of two installment payments of $12.5 ... results was a one-time $1.8 million payment from Genentech for ...
Breaking Biology Technology:Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3... China, May 26 /Xinhua-PRNewswire/ -- WuXi PharmaTech ... device research,and development outsourcing company with operations ... announced that it has appointed Dr. Peng ... (Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO ), Prior ...
... In Europe, Less Screening and Treatment, and an Apparent Higher ... of Hip Fracture Than in North America and Australia, ... one in four women surveyed from Europe, North America, and,Australia ... of 45,years. Among women considered to be at high risk ...
... Inc. (Nasdaq:,BHRT) announced that on May 21, 2008 ... (the "Nasdaq Letter") advising that, for the last ... listed securities,had been below the minimum $50,000,000 requirement ... to Nasdaq Marketplace Rule,4450(b)(1)(A). Furthermore, Nasdaq stated that ...
Other Biology Technology:WuXi PharmaTech (NYSE: WX) Appoints Dr. Peng Wang as VP of Discovery Biology 2Global Study Reveals Differences in Standard of Care for Osteoporosis Across the World 2Global Study Reveals Differences in Standard of Care for Osteoporosis Across the World 3Global Study Reveals Differences in Standard of Care for Osteoporosis Across the World 4Bioheart, Inc. Reports Receipt of Notification from NASDAQ Regarding Non-Compliance with Continued Listing Requirements 2... Purity is >95%NEN Radiolabeled Ligands\n\nReceptor-related research has ... of new radiolabeled ligands selected to keep ... wide range of products and services for ... 400 state-of-the-art radioligands. If you do not ...
... DNA polymerase is an antibody-mediated ... both conventional and real-time PCR ... at a concentration of 5 ... 5,000 units polymerase, 25 ml ...
... the formation of a phosphodiester bonds between ... duplex DNA molecules or between oligonucleotides which ... at 45 - 65?. Tfi DNA Ligase ... temperatures than conventional DNA ligases, Thus, Tfi ...
... GELase Agarose Gel-Digesting Preparation contains a unique ... simple, quantitative recovery of intact DNA and ... gels following electrophoresis in TAE, TBE, MOPS, ... digested directly in the TAE, TBE, MOPS, ...
Biology Products: